Community
2026/4/23
Healthcare GenAI at a Turning Point: From Hype to Real-World Evidence
Healthcare GenAI is at a turning point: recent studies show that while models perform well, real-world clinical impact is limited by adoption, workflow integration, and safety. The field is shifting from hype to evidence—emphasizing evaluation in real clinical settings, continuous monitoring, and lifecycle oversight. Regulatory and technical advances are aligning toward real-world validation rather than pre-deployment proof. The key challenge now is not better models, but building systems that continuously learn from practice. GenAI combined with Learning Health Systems offers a path to scalable, equitable, and predictive precision healthcare.
2025/12/15
At the Chen Institute’s AI Accelerated Science Symposium on October 28, 2025, ELHS Institute founder Dr. AJ Chen proposed a new vision for Open Clinical AI Science (OCAIS) to accelerate the clinical impact of generative AI. The framework delivers free GenAI-based disease prediction services to clinical teams worldwide, including low-resource settings, enabling large-scale participation in clinical evidence generation. By converging GenAI with task-specific Learning Health System units, this approach aims to shorten evidence-generation timelines from decades to years and help prevent GenAI from repeating past failures in health care innovation.
2025/10/25
Dr. AJ Chen delivered a keynote at the Tsinghua Health AI Summit on converging generative AI (GenAI) and Learning Health Systems (LHS) to improve clinical diagnosis and reduce global health disparities. He presented the ELHS Institute’s ML-enabled LHS framework, supported by Nature- and JAMIA-published studies, showing how GenAI embedded in LHS units can enable scalable, responsible evidence generation and democratize high-standard predictive care worldwide.
